Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin

• Published in: Journal of investigative dermatology Vol. 113; no. 3; pp. 415 - 418
• Main Authors: Chiodino, C, Cesinaro, A M, Ottani, D, Fantini, F, Giannetti, A, Trentini, G P, Pincelli, C
• Format: Journal Article
• Language: English
• Published: United States 01-09-1999
• Subjects: Adult; Apoptosis - drug effects; Humans; Immunoblotting; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Proteins - analysis; Skin - chemistry; Skin Neoplasms - chemistry
• ISSN: 0022-202X

Apoptosis plays a fundamental part in epidermal homeostasis, and apoptotic cells have been detected in normal and diseased skin. Little is known, however, on the inhibitory mechanisms of apoptosis at the skin level. In addition to bcl-2, a novel inhibitor of apoptosis designated survivin and structurally analogous to IAP apoptosis inhibitors has been recently identified. The expression of survivin in normal and pathologic skin was investigated. Immunohistochemical studies revealed that survivin is expressed in basal keratinocytes, but not in suprabasal epidermal layers, with a pattern similar to bcl-2. In western blots, the anti-survivin antibody recognized a single band of 16.5 kDa in protein extracts from normal human keratinocytes in culture, in agreement with the predicted size of survivin. In addition, survivin immunoreactivity was detected in benign and malignant melanocytic lesions, with strong expression in invasive lesions of melanomas. Whereas survivin staining was undetectable in benign epithelial tumors, such as seborrheic keratoses, it was observed in all epidermal layers in Bowen's disease. Interestingly, at variance with bcl-2, survivin was markedly expressed in squamous cell carcinoma, but virtually lacking in basal cell carcinoma, suggesting that these two apoptosis inhibitors may act through different anti-apoptotic pathways. Deregulation of survivin may influence both epidermal homeostasis and the development of melanoma and nonmelanoma skin cancer.